Eko Low Ejection Fraction Tool (ELEFT) vs ClearRead CT
AI Verdict
Choose Eko Low Ejection Fraction Tool (ELEFT) if…
Choose Eko Low Ejection Fraction Tool (ELEFT) if your practice prioritizes early, non-invasive screening for heart failure risk during routine physical examinations. This tool is ideal for primary care physicians, family medicine practitioners, or general cardiologists who need an AI-powered solution integrated with digital stethoscopes to quickly identify low ejection fraction at the point of care, aiding in timely referrals.
View Eko Low Ejection Fraction Tool (ELEFT) →Choose ClearRead CT if…
Choose ClearRead CT if your radiology department or specialty practice requires advanced AI for the precise analysis and interpretation of cardiothoracic CT scans. This solution is best suited for radiologists and pulmonologists aiming to enhance pulmonary nodule detection, characterize nodules, and perform coronary artery calcification scoring, thereby improving diagnostic accuracy and optimizing reading workflows for detailed CT interpretation.
View ClearRead CT →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Low Ejection Fraction Tool (ELEFT) | ClearRead CT |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Unknown | On-premise (stand-alone server, virtual machine) and Cloud |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Low Ejection Fraction Tool (ELEFT)ELEFT integrates with a familiar, non-invasive tool (digital stethoscope) to provide rapid results during routine physical exams, making it highly accessible and easy to use for a broad range of clinicians. ClearRead CT, while streamlining radiology workflows, operates within a more specialized and complex imaging environment.
Clinical Value
TieBoth tools are FDA-cleared and offer significant clinical value in their respective domains. ELEFT aids in the early detection of heart failure risk during routine exams, potentially enabling earlier intervention, while ClearRead CT improves diagnostic accuracy for critical conditions like pulmonary nodules and coronary artery calcification in imaging.
Pricing & Value
TieBoth ELEFT and ClearRead CT require contacting the vendor for specific pricing details, indicating a lack of transparency. Without access to their pricing models or detailed return on investment (ROI) data, it is not possible to differentiate their value propositions.
Enterprise Readiness
ClearRead CTClearRead CT explicitly highlights 'seamless PACS integration' and 'vendor-neutral processing,' which are critical for enterprise adoption in radiology environments. Its flexible deployment options (on-premise and cloud) also cater to diverse IT infrastructures, giving it an edge in enterprise readiness compared to ELEFT's cloud-only, platform-specific deployment.
Innovation
Eko Low Ejection Fraction Tool (ELEFT)ELEFT's innovation lies in integrating AI-powered cardiac screening into a routine physical exam via a digital stethoscope, making advanced detection more accessible and faster at the point of care. While ClearRead CT's patented vessel suppression and automated nodule tracking are significant advancements in radiology, ELEFT's application broadens the scope of AI-assisted diagnostics in a more disruptive way.
Support & Docs
TieBoth Eko Health and Riverain Technologies provide support sections on their websites, offering FAQs, user manuals, and contact information for assistance. Without more specific comparative details on the depth, responsiveness, or quality of their support and documentation, it is not possible to determine a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Low Ejection Fraction Tool (ELEFT) | ClearRead CT |
|---|---|---|
| Tool Name | Eko Low Ejection Fraction Tool (ELEFT) | ClearRead CT |
| Company | Eko Health | RIVERAIN TECHNOLOGIES |
| Description | The Eko Low Ejection Fraction Tool (ELEFT) is an FDA-cleared AI algorithm that integrates with Eko digital stethoscopes to aid clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams. | ClearRead CT is an FDA-cleared AI suite by Riverain Technologies for cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans. It improves diagnostic accuracy, reduces reading times, and streamlines radiology workflows through advanced AI and vessel suppression technology. |
| Primary Categories | Cardiology AI, Clinical Decision Support & Reference | Cardiology AI, Oncology AI, Radiology & Imaging AI |
| Key Features | AI-powered low ejection fraction detection, Integrates with FDA-cleared Eko digital stethoscopes, Analyzes ECG and heart sound recordings, Provides results in approximately 15 seconds, Part of the SENSORAu2122 Cardiac Early Detection Platform, Cloud-based data processing and storage, Aids in early identification of heart failure risk, Non-invasive screening tool | Pulmonary Nodule Detection (solid, part-solid, ground glass), Patented Vessel Suppression (Clear Visual Intelligence), Nodule Characterization and Measurement (volume, diameter, location, type, depth), Automated Nodule Tracking and Comparison to Prior Exams, Coronary Artery Calcification (CAC) Scoring (ungated, non-contrast CTs), Reduced Reading Time (up to 36%), Improved Detection Accuracy (29% reduction in missed actionable nodules), Seamless PACS Integration / Vendor-neutral processing |
Videos
Demos, reviews, and walkthroughs featuring Eko Low Ejection Fraction Tool (ELEFT) and ClearRead CT.
Frequently Asked Questions
More Comparisons
More matchups featuring Eko Low Ejection Fraction Tool (ELEFT) or ClearRead CT
Backers
Who funded each tool's parent company.